High-throughput screening and small animal models, where are we?
Jean Giacomotto1, Laurent Ségalat
1Université Claude Bernard Lyon, Villeurbanne, France. giacomottojean@gmail.com <giacomottojean@gmail.com>
British Journal of Pharmacology
|April 29, 2010
Summary
Screening drug candidates in whole organisms like C. elegans, Drosophila, and zebrafish offers advantages over traditional methods. These cost-effective animal models enable high-throughput screening for improved drug discovery and safety profiling.
Area of Science:
- Pharmacology and Toxicology
- Genetics and Genomics
- Developmental Biology
Background:
- Traditional high-throughput screening (HTS) for drug discovery relies on predefined molecular targets, often leading to invalid hits in later stages.
- The murine model (Mus musculus) is widely used but its high cost restricts its application in large-scale therapeutic screening.
- Limitations of target-based screening necessitate alternative approaches for identifying effective and safe drug candidates.
Purpose of the Study:
- To review the utility of alternative whole-animal models for large-scale drug discovery screening.
- To discuss the advantages of using C. elegans, Drosophila melanogaster, and Danio rerio as screening tools.
- To explore how these models bypass limitations of traditional HTS and target-dependent approaches.
Main Methods:
- Literature review of current high-throughput screening methodologies in drug discovery.
- Comparative analysis of different animal models for their suitability in large-scale screening.
- Evaluation of genetic amenability, cost-effectiveness, and culture conditions for screening applications.
Main Results:
- Caenorhabditis elegans, Drosophila melanogaster, and Danio rerio offer cost-effective, genetically tractable platforms for HTS.
- These models facilitate screening in a whole-animal context, identifying compounds with potential in vivo efficacy.
- Screening in these organisms is independent of prior target identification and aids in selecting compounds with better safety profiles.
Conclusions:
- Whole-animal screening using C. elegans, Drosophila, and zebrafish presents a versatile and efficient alternative to traditional drug discovery methods.
- These models enhance the identification of viable drug candidates by enabling early assessment of efficacy and safety.
- The adoption of these alternative models can accelerate therapeutic development and reduce costs in drug discovery pipelines.
More Related Videos
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...


